These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 19682357
1. Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing. Wang H, Kong F, Sorrell TC, Wang B, McNicholas P, Pantarat N, Ellis D, Xiao M, Widmer F, Chen SC. BMC Microbiol; 2009 Aug 14; 9():167. PubMed ID: 19682357 [Abstract] [Full Text] [Related]
2. Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates. Strzelczyk JK, Slemp-Migiel A, Rother M, Gołąbek K, Wiczkowski A. Acta Biochim Pol; 2013 Aug 14; 60(4):547-52. PubMed ID: 24340302 [Abstract] [Full Text] [Related]
3. Investigation of mutations in Erg11 gene of fluconazole resistant Candida albicans isolates from Turkish hospitals. Manastır L, Ergon MC, Yücesoy M. Mycoses; 2011 Mar 14; 54(2):99-104. PubMed ID: 19732347 [Abstract] [Full Text] [Related]
4. In vitro fluconazole susceptibility of 1,903 clinical isolates of Candida albicans and the identification of ERG11 mutations. Ying Y, Zhao Y, Hu X, Cai Z, Liu X, Jin G, Zhang J, Zhang J, Liu J, Huang X. Microb Drug Resist; 2013 Aug 14; 19(4):266-73. PubMed ID: 23484590 [Abstract] [Full Text] [Related]
5. Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG11 gene. Feng LJ, Wan Z, Wang XH, Li RY, Liu W. Chin Med J (Engl); 2010 Mar 05; 123(5):544-8. PubMed ID: 20367978 [Abstract] [Full Text] [Related]
6. Overexpression and mutation as a genetic mechanism of fluconazole resistance in Candida albicans isolated from human immunodeficiency virus patients in Indonesia. Rosana Y, Yasmon A, Lestari DC. J Med Microbiol; 2015 Sep 05; 64(9):1046-1052. PubMed ID: 26297039 [Abstract] [Full Text] [Related]
7. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Morio F, Loge C, Besse B, Hennequin C, Le Pape P. Diagn Microbiol Infect Dis; 2010 Apr 05; 66(4):373-84. PubMed ID: 20226328 [Abstract] [Full Text] [Related]
8. The new mutation L321F in Candida albicans ERG11 gene may be associated with fluconazole resistance. Oliveira Carvalho V, Okay TS, Melhem MS, Walderez Szeszs M, del Negro GM. Rev Iberoam Micol; 2013 Apr 05; 30(3):209-12. PubMed ID: 23402828 [Abstract] [Full Text] [Related]
9. A newly identified amino acid substitution T123I in the 14α-demethylase (Erg11p) of Candida albicans confers azole resistance. Wu Y, Gao N, Li C, Gao J, Ying C. FEMS Yeast Res; 2017 May 01; 17(3):. PubMed ID: 28334124 [Abstract] [Full Text] [Related]
10. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations. Xu Y, Chen L, Li C. J Antimicrob Chemother; 2008 Apr 01; 61(4):798-804. PubMed ID: 18218640 [Abstract] [Full Text] [Related]
11. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans. Feng W, Yang J, Xi Z, Qiao Z, Lv Y, Wang Y, Ma Y, Wang Y, Cen W. Microb Drug Resist; 2017 Jul 01; 23(5):563-570. PubMed ID: 27976986 [Abstract] [Full Text] [Related]
12. ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates. Xu Y, Sheng F, Zhao J, Chen L, Li C. Arch Microbiol; 2015 Nov 01; 197(9):1087-93. PubMed ID: 26349561 [Abstract] [Full Text] [Related]
13. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India. Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, Risbud A. Mycoses; 2016 Feb 01; 59(2):93-100. PubMed ID: 26648048 [Abstract] [Full Text] [Related]
14. Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans. Flowers SA, Colón B, Whaley SG, Schuler MA, Rogers PD. Antimicrob Agents Chemother; 2015 Jan 01; 59(1):450-60. PubMed ID: 25385095 [Abstract] [Full Text] [Related]
15. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China. Liu JY, Shi C, Wang Y, Li WJ, Zhao Y, Xiang MJ. Res Microbiol; 2015 Apr 01; 166(3):153-61. PubMed ID: 25748216 [Abstract] [Full Text] [Related]
16. Evaluation of the V404I and V509M amino acid substitutions of ERG11 gene in Candida albicans isolates by pyrosequencing. Kim TH, Lee MK. Folia Microbiol (Praha); 2010 May 01; 55(3):301-4. PubMed ID: 20526846 [Abstract] [Full Text] [Related]
17. Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China. Ge SH, Wan Z, Li J, Xu J, Li RY, Bai FY. Antimicrob Agents Chemother; 2010 Aug 01; 54(8):3126-31. PubMed ID: 20516286 [Abstract] [Full Text] [Related]
18. An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans. Heilmann CJ, Schneider S, Barker KS, Rogers PD, Morschhäuser J. Antimicrob Agents Chemother; 2010 Jan 01; 54(1):353-9. PubMed ID: 19884367 [Abstract] [Full Text] [Related]
19. Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans. Flowers SA, Barker KS, Berkow EL, Toner G, Chadwick SG, Gygax SE, Morschhäuser J, Rogers PD. Eukaryot Cell; 2012 Oct 01; 11(10):1289-99. PubMed ID: 22923048 [Abstract] [Full Text] [Related]
20. Delineation of the Direct Contribution of Candida auris ERG11 Mutations to Clinical Triazole Resistance. Rybak JM, Sharma C, Doorley LA, Barker KS, Palmer GE, Rogers PD. Microbiol Spectr; 2021 Dec 22; 9(3):e0158521. PubMed ID: 34878305 [Abstract] [Full Text] [Related] Page: [Next] [New Search]